Your browser doesn't support javascript.
loading
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.
Barnes, Daniel R; Silvestri, Valentina; Leslie, Goska; McGuffog, Lesley; Dennis, Joe; Yang, Xin; Adlard, Julian; Agnarsson, Bjarni A; Ahmed, Munaza; Aittomäki, Kristiina; Andrulis, Irene L; Arason, Adalgeir; Arnold, Norbert; Auber, Bernd; Azzollini, Jacopo; Balmaña, Judith; Barkardottir, Rosa B; Barrowdale, Daniel; Barwell, Julian; Belotti, Muriel; Benitez, Javier; Berthet, Pascaline; Boonen, Susanne E; Borg, Åke; Bozsik, Aniko; Brady, Angela F; Brennan, Paul; Brewer, Carole; Brunet, Joan; Bucalo, Agostino; Buys, Saundra S; Caldés, Trinidad; Caligo, Maria A; Campbell, Ian; Cassingham, Hayley; Christensen, Lise Lotte; Cini, Giulia; Claes, Kathleen B M; Cook, Jackie; Coppa, Anna; Cortesi, Laura; Damante, Giuseppe; Darder, Esther; Davidson, Rosemarie; de la Hoya, Miguel; De Leeneer, Kim; de Putter, Robin; Del Valle, Jesús; Diez, Orland; Ding, Yuan Chun.
Affiliation
  • Barnes DR; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Silvestri V; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Leslie G; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Yang X; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Adlard J; Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.
  • Agnarsson BA; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
  • Ahmed M; School of Medicine, University of Iceland, Reykjavik, Iceland.
  • Aittomäki K; North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, UK.
  • Andrulis IL; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Arason A; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Arnold N; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Auber B; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
  • Azzollini J; BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Balmaña J; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
  • Barkardottir RB; Institute of Clinical Molecular Biology, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
  • Barrowdale D; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Barwell J; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Belotti M; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Hospital Campus, Barcelona, Spain.
  • Benitez J; Department of Medical Oncology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Berthet P; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
  • Boonen SE; BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Borg Å; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Bozsik A; Leicestershire Clinical Genetics Service, University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Brady AF; Service de Génétique, Institut Curie, Paris, France.
  • Brennan P; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
  • Brewer C; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Brunet J; Département de Biopathologie, Centre François Baclesse, Caen, France.
  • Bucalo A; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
  • Buys SS; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Caldés T; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
  • Caligo MA; North West Thames Regional Genetics Service, London North West University Healthcare NHS Trust, Northwick Park Hospital, Harrow, UK.
  • Campbell I; Northern Genetics Service, Newcastle Hospitals NHS Foundation Trust, Newcastle, UK.
  • Cassingham H; Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, UK.
  • Christensen LL; Hereditary Cancer Program, Oncobell-IDIBELL-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.
  • Cini G; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Claes KBM; Department of Internal Medicine, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA.
  • Cook J; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
  • Coppa A; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Cortesi L; Department of Internal Medicine, Division of Human Genetics, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Damante G; Division of Surgical Oncology, National Cancer Centre, Singapore, Singapore.
  • Darder E; Division of Functional Onco-Genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Davidson R; Centre for Medical Genetics, Ghent University, Gent, Belgium.
  • de Putter R; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
  • Del Valle J; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
  • Diez O; Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.
  • Ding YC; Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.
J Natl Cancer Inst ; 114(1): 109-122, 2022 01 11.
Article in En | MEDLINE | ID: mdl-34320204
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 / Humans / Male Language: En Journal: J Natl Cancer Inst Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 / Humans / Male Language: En Journal: J Natl Cancer Inst Year: 2022 Document type: Article Affiliation country: